Nationwide Children’s gene therapy spinout raises $2.5M to test muscular dystrophy treatment

Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.

A gene therapy startup that spun out of Nationwide Children’s Hospital six months ago has raised $2.5 million toward testing a treatment for a form of muscular dystrophy in patients.

Myonexus Therapeutics Inc. is the fourth company to come out of gene therapy research at the Columbus hospital and the only one located in Central Ohio.

Click here to read the complete article, and see related press release.
Originally published December 13, 2017.